LIFE SCIENCES
From submission to approval: streamlining global regulatory operations
A global leader in consumer health, requires seamless regulatory oversight to manage its diverse portfolio of medicines and supplements across international markets. ALTEN provides specialised support to their CMC (Chemistry, Manufacturing, and Controls) team, ensuring that complex product variations, annual reports, and regulatory submissions are prepared with precision and compliance to facilitate rapid product availability.
The challenge
Operating in a highly competitive consumer health market requires a high degree of agility in managing product life cycles while maintaining strict compliance with international health authority requirements, including EMA and Rest‑of‑World (ROW) regulations. The client faced the complexity of coordinating change requests across multiple regions simultaneously, each governed by distinct regulatory timelines and documentation expectations. This was further intensified by the need to deliver submission excellence, ensuring the accurate preparation, quality review, and timely finalisation of critical regulatory packages such as variations, renewals, and annual reports. Success also depended on strong cross‑functional alignment, with regulatory strategies needing to be clearly communicated, understood, and consistently implemented across international affiliates.
The solution
ALTEN acts as the regulatory backbone, ensuring compliance and market access:
- Lifecycle Management: Evaluating and defining the regulatory impact of changes, ensuring all documentation is ready for timely submission.
- Strategy & Query Management: Defining clear regulatory strategies for product variations and proactively addressing regulatory queries (Q&A) from health authorities.
- Process Standardisation: Overseeing internal workflows to ensure consistency and transparency across all regional affiliates. vities.
Results & benefits
Our partnership with the client has significantly streamlined their regulatory operations:
- Accelerated Approvals: By ensuring high-quality, “first-time-right” submissions, we have minimised delays and supported timely product availability in global markets.
- Risk Mitigation: Our accurate and consistent documentation practices have substantially reduced regulatory non-compliance risks.
- Enhanced Transparency: Improved visibility into approval progress and regulatory outcomes, allowing for better strategic decision-making.
Key project takeaways
Reflecting on this engagement, a few themes stood out as essential to regulatory success in a highly competitive consumer health environment. A well‑defined regulatory strategy acted as a true business accelerator, enabling faster market access rather than simply ensuring compliance. Efficiency was driven by strong coordination between headquarters and international affiliates, allowing regulatory activities to scale smoothly across regions. This was ultimately reinforced by the synergy of expertise, where deep regulatory knowledge combined with solid project management enabled confident navigation of complex submission processes.
